TTNP Financial Statements

Balance sheet, income statement, cash flow, and dividends for Titan Pharmaceuticals Inc (TTNP).


$2.98M Market Cap.

As of 03/20/2025 5:00 PM ET (MRY) • Disclaimer

TTNP Market Cap. (MRY)


TTNP Shares Outstanding (MRY)


TTNP Assets (MRY)


Total Assets

$2.92M

Total Liabilities

$483.00K

Total Investments

$0

TTNP Income (MRY)


Revenue

$0

Net Income

-$4.71M

Operating Expense

$4.56M

TTNP Cash Flow (MRY)


CF Operations

-$3.88M

CF Investing

$0

CF Financing

-$62.00K

TTNP Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

TTNP Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$2,923,000 (-63.85%)

$8,086,000 (99.26%)

$4,058,000 (-49.24%)

$7,994,000 (-1.15%)

Assets Current

$2,923,000 (-63.54%)

$8,018,000 (122.54%)

$3,603,000 (-50.16%)

$7,229,000 (-1.35%)

Assets Non-Current

$0 (0%)

$68,000 (-85.05%)

$455,000 (-40.52%)

$765,000 (0.79%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$2,440,000 (-63.26%)

$6,642,000 (387.31%)

$1,363,000 (-73.47%)

$5,138,000 (45.47%)

Property Plant & Equipment Net

$0 (0%)

$68,000 (-83.29%)

$407,000 (-43.24%)

$717,000 (-5.53%)

Cash & Equivalents

$2,831,000 (-58.20%)

$6,773,000 (116.18%)

$3,133,000 (-50.52%)

$6,332,000 (16.98%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$12,000 (-93.88%)

$196,000 (-33.56%)

$295,000 (0%)

Total Investments

$0 (0%)

$1,000,000 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$1,000,000 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$106,000 (-63.82%)

$293,000 (-10.67%)

Trade & Non-Trade Receivables

$62,000 (34.78%)

$46,000 (27.78%)

$36,000 (-67.86%)

$112,000 (-87.33%)

Trade & Non-Trade Payables

$202,000 (-41.95%)

$348,000 (-49.93%)

$695,000 (-12.58%)

$795,000 (-36.55%)

Accumulated Retained Earnings (Deficit)

-$396,536,000 (-1.20%)

-$391,830,000 (-1.44%)

-$386,261,000 (-2.71%)

-$376,055,000 (-2.39%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$565,000 (202.14%)

$187,000 (-37.46%)

$299,000 (-63.04%)

Debt Current

$0 (0%)

$565,000 (363.11%)

$122,000 (8.93%)

$112,000 (-76.52%)

Debt Non-Current

$0 (0%)

$0 (0%)

$65,000 (-65.24%)

$187,000 (-43.67%)

Total Liabilities

$483,000 (-66.55%)

$1,444,000 (-46.42%)

$2,695,000 (-5.64%)

$2,856,000 (-37.30%)

Liabilities Current

$483,000 (-66.55%)

$1,444,000 (-45.10%)

$2,630,000 (-1.46%)

$2,669,000 (-36.80%)

Liabilities Non-Current

$0 (0%)

$0 (0%)

$65,000 (-65.24%)

$187,000 (-43.67%)

TTNP Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$184,000 (-66.97%)

$557,000 (-63.50%)

$1,526,000 (-68.46%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$199,000 (-57.84%)

Selling General & Administrative Expense

$4,557,000 (-17.86%)

$5,548,000 (-8.05%)

$6,034,000 (20.95%)

$4,989,000 (-14.00%)

Research & Development Expense

$0 (0%)

$1,913,000 (-59.79%)

$4,758,000 (-16.41%)

$5,692,000 (-3.79%)

Operating Expenses

$4,557,000 (-38.92%)

$7,461,000 (-30.87%)

$10,792,000 (1.04%)

$10,681,000 (-8.84%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$4,706,000 (15.50%)

-$5,569,000 (45.43%)

-$10,206,000 (-16.29%)

-$8,776,000 (51.89%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$4,706,000 (15.50%)

-$5,569,000 (45.43%)

-$10,206,000 (-16.29%)

-$8,776,000 (51.89%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$4,706,000 (15.50%)

-$5,569,000 (45.43%)

-$10,206,000 (-16.29%)

-$8,776,000 (51.89%)

Weighted Average Shares

$899,000 (19.55%)

$752,000 (-94.40%)

$13,434,000 (38.07%)

$9,730,000 (157.88%)

Weighted Average Shares Diluted

$899,000 (19.55%)

$752,000 (-94.40%)

$13,434,000 (38.07%)

$9,730,000 (157.88%)

Earning Before Interest & Taxes (EBIT)

-$4,706,000 (15.50%)

-$5,569,000 (45.43%)

-$10,206,000 (-16.29%)

-$8,776,000 (49.77%)

Gross Profit

$0 (0%)

$184,000 (-66.97%)

$557,000 (-58.03%)

$1,327,000 (-69.61%)

Operating Income

-$4,557,000 (37.38%)

-$7,277,000 (28.90%)

-$10,235,000 (-9.42%)

-$9,354,000 (-27.25%)

TTNP Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$732,000 (0%)

$0 (0%)

-$23,000 (95.74%)

Net Cash Flow from Financing

-$62,000 (-100.62%)

$10,000,000 (100.64%)

$4,984,000 (-43.63%)

$8,841,000 (-50.70%)

Net Cash Flow from Operations

-$3,880,000 (45.29%)

-$7,092,000 (13.33%)

-$8,183,000 (-3.60%)

-$7,899,000 (54.08%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$3,942,000 (-208.30%)

$3,640,000 (213.79%)

-$3,199,000 (-448.10%)

$919,000 (383.68%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$734,000 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

-$2,000 (0%)

$0 (0%)

-$23,000 (95.74%)

Issuance (Repayment) of Debt Securities

-$62,000 (-112.40%)

$500,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$0 (0%)

$0 (0%)

$4,984,000 (-43.63%)

$8,841,000 (-53.17%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$0 (0%)

$1,038,000 (-25.70%)

$1,397,000 (-9.34%)

$1,541,000 (21914.29%)

Depreciation Amortization & Accretion

$5,000 (-95.54%)

$112,000 (-42.86%)

$196,000 (-11.31%)

$221,000 (-24.32%)

TTNP Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

100.00% (0.00%)

100.00% (14.94%)

87.00% (-3.55%)

Profit Margin

-

-3026.60% (-65.18%)

-1832.30% (-218.61%)

-575.10% (-52.51%)

EBITDA Margin

-

-2965.80% (-65.03%)

-1797.10% (-220.57%)

-560.60% (-57.87%)

Return on Average Equity (ROAE)

-119.50% (27.97%)

-165.90% (24.97%)

-221.10% (-97.59%)

-111.90% (85.48%)

Return on Average Assets (ROAA)

-107.40% (-1.61%)

-105.70% (24.98%)

-140.90% (-72.46%)

-81.70% (56.19%)

Return on Sales (ROS)

-

-3026.60% (-65.18%)

-1832.30% (-218.61%)

-575.10% (-59.22%)

Return on Invested Capital (ROIC)

2704.60% (61.24%)

1677.40% (21.21%)

1383.90% (-50.68%)

2806.10% (609.00%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-0.62 (44.03%)

-1.11 (-8.06%)

-1.03 (9.09%)

-1.13 (-66.37%)

Price to Sales Ratio (P/S)

-

33.72 (78.52%)

18.89 (190.39%)

6.5 (153.47%)

Price to Book Ratio (P/B)

1.22 (30.87%)

0.93 (-88.90%)

8.4 (327.08%)

1.97 (-67.79%)

Debt to Equity Ratio (D/E)

0.2 (-8.76%)

0.22 (-89.02%)

1.98 (255.58%)

0.56 (-56.90%)

Earnings Per Share (EPS)

-5.23 (29.42%)

-7.41 (-875.00%)

-0.76 (15.56%)

-0.9 (81.37%)

Sales Per Share (SPS)

0 (0%)

0.24 (497.56%)

0.04 (-73.89%)

0.16 (-87.75%)

Free Cash Flow Per Share (FCFPS)

-4.32 (54.25%)

-9.43 (-1449.10%)

-0.61 (25.18%)

-0.81 (82.69%)

Book Value Per Share (BVPS)

2.71 (-69.27%)

8.83 (8644.55%)

0.1 (-80.87%)

0.53 (-43.59%)

Tangible Assets Book Value Per Share (TABVPS)

3.25 (-69.77%)

10.75 (3460.60%)

0.3 (-63.26%)

0.82 (-61.64%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

0 (0%)

-1 (0%)

0 (0%)

Enterprise Value Over EBITDA (EV/EBITDA)

0.24 (-2.07%)

0.24 (134.68%)

-0.69 (-96.88%)

-0.35 (73.46%)

Asset Turnover

0 (0%)

0.04 (-54.55%)

0.08 (-45.77%)

0.14 (-71.31%)

Current Ratio

6.05 (8.99%)

5.55 (305.33%)

1.37 (-49.43%)

2.71 (56.14%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$3,880,000 (45.31%)

-$7,094,000 (13.31%)

-$8,183,000 (-3.29%)

-$7,922,000 (55.35%)

Enterprise Value (EV)

-$1,111,597 (15.65%)

-$1,317,778 (-118.93%)

$6,960,140 (130.51%)

$3,019,441 (-86.78%)

Earnings Before Tax (EBT)

-$4,706,000 (15.50%)

-$5,569,000 (45.43%)

-$10,206,000 (-16.29%)

-$8,776,000 (51.89%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$4,701,000 (13.85%)

-$5,457,000 (45.48%)

-$10,010,000 (-17.01%)

-$8,555,000 (50.21%)

Invested Capital

-$391,000 (-190.09%)

$434,000 (128.59%)

-$1,518,000 (-114.41%)

-$708,000 (4.32%)

Working Capital

$2,440,000 (-62.88%)

$6,574,000 (575.64%)

$973,000 (-78.66%)

$4,560,000 (46.86%)

Tangible Asset Value

$2,923,000 (-63.85%)

$8,086,000 (99.26%)

$4,058,000 (-49.24%)

$7,994,000 (-1.15%)

Market Capitalization

$2,980,403 (-51.88%)

$6,194,222 (-45.93%)

$11,456,140 (13.29%)

$10,112,441 (-53.14%)

Average Equity

$3,938,000 (17.30%)

$3,357,250 (-27.26%)

$4,615,500 (-41.13%)

$7,840,250 (231.13%)

Average Assets

$4,380,250 (-16.82%)

$5,266,250 (-27.29%)

$7,242,750 (-32.57%)

$10,740,500 (9.80%)

Invested Capital Average

-$174,000 (47.59%)

-$332,000 (54.98%)

-$737,500 (-135.81%)

-$312,750 (-109.87%)

Shares

914,234 (21.77%)

750,815 (-94.87%)

14,629,217 (47.56%)

9,914,158 (51.16%)